▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3968 by analyst upside · 2026-09-28
BLLN
BillionToOne, Inc.
Healthcare · Market Cap $6B · P/E 173.4x
ANALYST PRICE TARGET
+0.5%
implied upside to consensus target
Current Price $123.08
Consensus Target $123.75
Bull Target $145.0
Bear Target $90.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
2
Sell
0
52-Week Low $61.96
52-Week High $150.44
YTD Return +37.8%
FUNDAMENTALS
Market Cap $6B
P/E Ratio (TTM) 173.4x
Forward P/E 82.9x
EPS (TTM) $0.71
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $397M
Profit Margin 8.3%
52-WEEK RANGE
52-Week Low $61.96
52-Week High $150.44
Current Price $123.08
Bear Target $90.0
Bull Target $145.0
● Now $123.08 ● Target $123.75
TRADING DATA
Avg Volume 699K
YTD Return +37.8%
Analyst Count 8
Consensus Buy
Upside to Target +0.5%
Last Updated 2026-09-28

ANALYST SUMMARY

BillionToOne, Inc. (BLLN) is currently trading at $123.08 with a Wall Street consensus price target of $123.75, implying potential upside of 0.5% over the next 12 months. 8 analysts currently cover BLLN, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $145.0, while the most cautious has a target of $90.0.

BLLN operates in the Healthcare sector with a market capitalisation of $6B. The stock is up 37.8% year-to-date and is currently trading near the upper end of its 52-week range of $61.96 – $150.44.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for BLLN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity ● Initiated
Buy 2026-09-02 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-08-06 43% win rate (7 calls)
BTIG - Reiterated
Buy → Buy 2026-08-06 38% win rate (8 calls)
Guggenheim ● Initiated
Buy → Buy 2026-06-29 62% win rate (8 calls)
Guggenheim - Reiterated
Buy → Buy 2026-05-13 62% win rate (8 calls)
JP Morgan - Reiterated
Overweight → Overweight 2026-05-07 43% win rate (7 calls)
BTIG - Reiterated
Buy → Buy 2026-05-07 38% win rate (8 calls)
Guggenheim - Reiterated
Buy → Buy 2026-03-30 62% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
52
out of 100
Coverage depth
17/30
Consensus clarity
21/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →